Pharmaceuticals

Achondroplasia Treatment Market is Estimated to Witness High Growth Owing to promising product pipeline and rising awareness

Purvaja

Achondroplasia Treatment Market is Estimated to Witness High Growth Owing to promising product pipeline and rising awareness

Achondroplasia is the most common type of dwarfism. It results in an abnormal bone growth and disproportionately shorter arms and legs, as well as distinctive facial features such as an enlarged head and protruding forehead. The Achondroplasia Treatment includes recombinant human growth hormone, gene therapy, and bone lengthening surgery, which can help to increase height in people with achondroplasia. The treatment options address the underlying genetic defect and provide improved mobility and quality of life.

The global achondroplasia treatment market is estimated to be valued at US$127.8 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Promising product pipeline and growing awareness about treatment options are fuelling growth of the achondroplasia treatment market. Several pharmaceutical companies are developing pipeline candidates that target the underlying cause of achondroplasia rather than just managing symptoms. Some notable candidates in clinical trials include BioMarin's vosoritide, Ascendis Pharma's TransCon CNP and PhaseBio’s investigational product for achondroplasia. Moreover, support organizations like Achondroplasia Forward are raising awareness and advocacy efforts, which is positively impacting the market.

Porter’s Analysis

Threat of new entrants: Low-moderate as this market requires huge R&D investments and regulatory approvals for treatment. Bargaining power of buyers: Moderate as limited options are available in the market. Bargaining power of suppliers: Moderate as suppliers have pricing power due to specialized drugs. Threat of new substitutes: Low as treatment options are limited. Competitive rivalry: High as key players are aggressively expanding their pipeline molecules.

SWOT Analysis

Strength: Existing treatment options, growing public awareness. Weakness: High cost of treatment, low diagnosis rates. Opportunity: Rising prevalence, emerging economies. Threats: Stringent regulations, reimbursement issues.

Key Takeaways

The Global Achondroplasia Treatment Market is expected to witness high growth, exhibiting CAGR of 12 % over the forecast period, due to increasing prevalence of Achondroplasia disorder globally.

The US market currently dominates the global Achondroplasia Treatment market and is expected to grow at a CAGR of over 35% during the forecast period, due to the strong presence of major pharmaceutical players, rising healthcare expenditure in the region. The Asia Pacific region is expected to be the fastest growing market exhibiting a CAGR of over 38% during the forecast period due to huge patient pool, rising geriatric population, and increasing medical tourism in countries like India, China and Japan.

Key players operating in the Achondroplasia Treatment market are BioMarin, RIBOMIC, Ascendis Pharma A/S, BridgeBio Pharma, Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc., SiSaf, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, LG Chem, Ferring B.V., JCR Pharmaceuticals Co., Ltd, KVK TECH, INC., VIVUS LLC., ProLynx Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Ipsen Pharma, Novartis AG, and Xiamen Amoytop Biotech Co., Ltd. These players are focused on expanding their product portfolio by developing new and innovative therapies for more effective treatment of Achondroplasia through mergers, acquisitions and partnerships.

For more insights, Read- https://www.pressreleasebulletin.com/achondroplasia-treatment-market-demand-size-and-insights/

Purvaja

Gene Therapy Segment Is Fastest Growing Segment Fueling The Growth Of Achondroplasia Treatment Market

Sushil Mahalle's Articles 2023-11-20

Emerging gene therapies aim to directly address the underlying FGFR3 gene mutation in order to stimulate bone growth and prevent spinal complications. Further development of these therapies is anticipated to drive significant growth of the achondroplasia treatment market in the forecast period. The global Achondroplasia Treatment Market Demand is estimated to be valued at US$ 127. Segment Analysis The global achondroplasia treatment market is segmented into drug type, distribution channel and end user. Regional analysis North America accounts for the largest share in the global achondroplasia treatment market due to high healthcare expenditure and availability of resources for clinical trials.

Achondroplasia Therapeutics Market Insight | Outlook | Growth Analysis Report 2022-2028

Sofia Kausar 2022-06-10

Moreover, the report also highlights a sudden occurrence of COVID-19 impact on Achondroplasia Therapeutics market to improve future capacities and other developments. The entire Achondroplasia Therapeutics market has been sub-categorized into treatment type and end-user. Request a FREE Sample Copy of Global Achondroplasia Therapeutics Market Report with Full TOC At: https://www. The major players in the achondroplasia therapeutics market include Ascendis Pharma A/S, BioMarin Pharmaceutical Inc. Purchase complete Global Achondroplasia Therapeutics Market Research Report At: https://www.

Achondroplasia Treatment Market 2019 Insights, Industry Key Players, Global Trends, Sales, Supply, Demand, Analysis & Forecast to 2026| Esticast Research

Bhavika Agrawal 2020-01-07

The “Global Achondroplasia Treatment Market 2018-2026 research report” presented by Esticast Research and Consulting offers a clear picture of the current market scenario that includes past records till projected future, size about value and volume, and micro and macro factors in the global market.

The perspectives mentioned in the report direct the clients to analyze the market and designed several strategies for the industry growth of the Achondroplasia Treatment market.

The Achondroplasia Treatment market report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market.About Achondroplasia Treatment MarketAchondroplasia is a genetic disorder caused due to heredity or mutation of FGFR3 genes during sperm or egg development.

Every 1 individual out of 25,000 births is affected by achondroplasia.

At present, there is no prevention nor cure for achondroplastic dwarfism, due to which, the treatment is majorly focused on minimizing the complications such as sleep apnea, obesity, and arthritis.

Research studies are focusing on the mutational changes occurring in the FGFR3 gene in order to identify the exact cause of achondroplasia and introduce a cure for it.

Global Achondroplasia Therapeutics Market 2020 - Top Key Players Analysis Report Till 2027

Aarohi Maloniya 2021-08-12

Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Achondroplasia Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/achondroplasia-therapeutics-market/download-sampleMarket DynamicsThe growing burden of achondroplasia is driving the growth of the market.

Inadequate reimbursement, lack of awareness, and short duration effectiveness of growth hormone therapy are projected to hamper the market growth.

Genetic research on achondroplasia revealed two novel mutations, thus helping to complete the pathological molecular map of achondroplasia.

Still, there is a need to validate these approaches in preclinical models of achondroplasia.

Favorable results of validation will create opportunities for the market.

Achondroplasia Therapeutics Market Analysis & Trends Report 2028 - Value Market Research

Noora Sinha 2022-04-13

The major players in the achondroplasia therapeutics market include Ascendis Pharma A/S, BioMarin Pharmaceutical Inc. Get more information on "Global Achondroplasia Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Achondroplasia Therapeutics Market Research Report with detailed TOC at https://www. By Treatment Type · Growth Hormone Therapy· Surgery· Supportive TherapyBy End-User· Hospitals· Specialty Clinics· Retail Pharmacies· OthersRegional AnalysisThis section covers regional segmentation which accentuates on current and future demand for achondroplasia therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Purchase Complete Global Achondroplasia Therapeutics Market Research Report at https://www.

Alopecia Treatment Market Growth Accelerated by Rising Prevalence of Hair Loss Conditions

ashwinicmi 2024-01-18

These products provide nourishment to hair follicles and promote hair growth. The prevalence of alopecia and other hair loss conditions has been increasing significantly worldwide due to rising levels of mental stress, pollution and genetic factors. The higher occurrence of other hair loss conditions such as androgenic alopecia and telogen effluvium is also pushing the demand for alopecia treatments. Key TakeawaysThe Global Alopecia Treatment Market Size is expected to witness high growth during 2023-2030 on back of rising awareness, effective marketing by pharma companies and increasing prevalence of alopecia disorders worldwide. Key players operating in the alopecia treatment market are Shiseido, Cipla, Merck, Johnson & Johnson, Sun Pharmaceuticals, Transitions Hair, Lexington International and Cirrus Hair Transplant.

WHO TO FOLLOW

MORE FROM AUTHOR

Shipping Containers: From Ship to Shore to Everywhere

Purvaja 2024-04-16

Soundproofing the World: The Quiet Revolution - Advancements in Global Acoustic Insulation

Purvaja 2024-04-16

Aesthetic Excellence: The Beauty and Functionality of Acrylic Teeth

Purvaja 2024-04-12

Flying Innovation: Exploring the World of Unmanned Aerial Vehicle Drones

Purvaja 2024-04-12

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Reviving Your Locks: Cutting-Edge Techniques for Alopecia Treatment

Anjali Pawar 2023-03-31

It can occur in different forms, such as male-pattern baldness, female-pattern baldness, and alopecia areata, among others. Fortunately, there are various treatments available that can help manage alopecia and promote hair growth. It works by widening blood vessels in the scalp, which improves blood flow and promotes hair growth. The platelets contain growth factors that can stimulate hair growth and improve the health of the hair follicles. It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone that is known to cause hair loss.

Prevention of Data Breach to Be the Top Priority of Endocarditis Treatment Market

Persistence Market Research 2022-02-23

The rise in the rare disease in the field of cardiology is expected to boost the demand for infective endocarditis treatment options, hence, indirectly will boost the market growth of infective endocarditis treatment market. This factor may hamper the infective endocarditis treatment of market growth. In recent years, it has been observed that the incidence rate of infective endocarditis has remained comparatively constant, but the infective endocarditis epidemiology has changed prominently. This has gained a lot of popularity and attention of researchers and acts as the key factor to increase the market growth of endocarditis treatment market. This factor may hamper the infective endocarditis treatment of market growth. Some of the key players in the Infective endocarditis treatment market include Novartis International AG, Sun Pharmaceutical Industries Ltd.

Global Seed Treatment Market Research Report 2022-2028

prachiti sharma 2022-12-02

Bharat Book Bureau Provides the Trending Market Research Report on “Global Seed Treatment Market 2022-2028” under Food & Beverage Market Research Report Category. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global seed treatment market. Based on application technique, the seed treatment market is segmented into: seed coating, seed pelleting, seed dressing, others. On the basis of function, the seed treatment market also can be divided into: seed protection, seed enhancement, others. Scope of the Report- To analyze and forecast the market size of the global seed treatment market.

Hyperphosphatemia Treatment Market Future Trends 2022: Advance Technology, Business Overview, Demand, Revenue To 2031

Pooja tbrc 2022-05-05

id=5852&type=smp The global hyperphosphatemia treatment market size is expected to grow from $3. The global hyperphosphatemia treatment market share is expected to grow to $5. Africa Hyperphosphatemia Treatment Market 27. Key Mergers And Acquisitions In The Hyperphosphatemia Treatment Market 29. Appendix About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market to be driven at a CAGR of 7% in the Forecast Period of 2021-2026

Paul Flint 2021-03-18

The new report by Expert Market Research titled, ‘Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global ABSSSI market, assessing the market based on its segments like infection type, route of administration, distribution channel, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin America.

The sample report shall be delivered to you within 24 hours.Request a free sample copy in PDF or view the report summary@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market/requestsampleThe key highlights of the report include:Market Overview (2021-2026)Historical Market Size (2020): USD 9.3 BillionForecast CAGR (2021-2026): 7%Forecast Market Size (2026): USD 14 BillionThe growth of global ABSSSI is driven by the rising prevalence of skin infections.

Additionally, the developing antibiotic resistance in pathogenic bacteria, and mutations resulting in the newer strains is expected to drive the demand for the ABSSI Market.

Further the government spending on healthcare and infrastructure will propel the market in the forecast period.Industry Definition and Major SegmentsABSSSI are mild or severe forms infections caused by pathogens like streptococcus pyogenes and Staphylococcus aureus.

These drugs are pathogen specific and may require surgical excision of lesion in extreme cases.Explore the full report with the table of contents@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-marketThe acute bacterial skin and skin structure infections (ABSSSI) treatment industry can be segmented by infection type:Hospital-acquired ABSSSICommunity-acquired ABSSSIOthersIt may be differentiated on the basis of route of administration:OralParenteralThe industry may be classified on the basis of distribution channel:Hospital PharmacyRetail PharmacyOnlineOthersLatest Global News on Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market@https://www.expertmarketresearch.com/pressrelease/global-absssi-treatment-marketOn the basis of regional markets, the industry is divided into:1 North America1.1 United States of America1.2 Canada2 Europe2.1 Germany2.2 United Kingdom2.3 France2.4 Italy2.5 Others3 Asia Pacific3.1 China3.2 Japan3.3 India3.4 ASEAN3.5 Others4 Latin America4.1 Brazil4.2 Argentina4.3 Mexico4.4 Others5 Middle East & Africa5.1 Saudi Arabia5.2 United Arab Emirates5.3 Nigeria5.4 South Africa5.5 OthersMarket TrendsRegionally, North America is the largest shareholder in the global ABSSSI market, due to the presence of a robust healthcare system.

This can be attributed to the rapidly advancing healthcare sector, increasing population, and growing awareness about various skin aliments.Key Market PlayersThe major players in the market are Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., GlaxoSmithKline plc, and a few others.

Global Tracheitis Treatment Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Uday Kiran 2024-04-01

The tracheitis treatment market size is expected to see steady growth in the next few years. The regions covered in tracheitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Therefore, the rising incidence of smoking is driving the growth of the tracheitis treatment market. The tracheitis treatment market report table of contents includes:Executive Summary Tracheitis Treatment Market Characteristics Tracheitis Treatment Market Trends And Strategies Tracheitis Treatment Market - Macro Economic ScenarioGlobal Tracheitis Treatment Market Size and Growth. Global Tracheitis Treatment Market Competitive BenchmarkingGlobal Tracheitis Treatment Market Competitive DashboardKey Mergers And Acquisitions In Tracheitis Treatment Market Tracheitis Treatment Market Future Outlook and Potential AnalysisAppendix Top Major Players :Pfizer Inc.

Scoliosis Treatment Market Demands, Insights, Research and Forecast 2020-2027

nilesh 2022-04-11

However, the high cost of treatment or procedures and limited understanding of the disorder and available treatment options are expected to curb the growth of the scoliosis treatment market. It is estimated that the global scoliosis treatment market size is expected to register a CAGR of~ 3. The global scoliosis treatment market is currently dominated by numerous market players. Key PlayersSome of the key players in the global scoliosis treatment market are NuVasive, Spinal Technology, Inc. com/reports/scoliosis-treatment-market-8230 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Keloid Treatment Market by revenue is expected to grow at a CAGR of 3.5% during the period 2018–2023

apekshaagarwal 2022-02-25

Growing awareness among patients about the new technological advancement in Keloid Treatment Market is the key factors that drive the growth of the market. As there is an increasing prevalence of keloid among people the demand for keloid treatment is increasing and hence there is an increase in keloid treatment market. The market in the Middle East & Africa is likely to account for the smallest share of the global keloid treatment market. Segmentation:The global keloid treatment market has been segmented into product, treatment, and end-users. com

What is Achondroplasia Treatment Market?

Ankit Nigam 2021-10-22

Achondroplasia is the most common of skeletal dysplasia that results in marked short stature (dwarfism).

It is a human bone genetic disorder of the growth plate and is the most common form of inherited disproportionate short stature.DelveInsight's "Achondroplasia Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some facts of Achondroplasia Market Report are:According to Columbia University Medical Center (CUMC), this disorder occurs in approximately 1 in 25,000 live births worldwide.The prevelance rates have correlation to father’s age as mutations occur exclusively in the male and older men who have a higher probability of having an affected child than younger ones (Deepali N.shinde et al)The population-based study conducted by DK.Waller et al in US, stated that the prevalence of de novo Achondroplasia has been significantly increased with age of father.

The prevelance data varied according to father’s age such as 25–29, 30–34, 35–39, and ≥40 years, with reported rates of 2.8, 2.8, 4.9 and 5.0 respectively.The prevalence of achondroplasia ranged from 0.36 to 0.60 per 10,000 livebirthsAccording to a study, the recurrence risk of Achondroplasia among siblings of an affected individual was found to be 0.23% (Mettler and Fraser)View Report: https://www.delveinsight.com/report-store/achondroplasia-marketRequest for Sample Report: https://www.delveinsight.com/sample-request/achondroplasia-marketScope of the Achondroplasia Market ReportThe report covers the descriptive overview of Achondroplasia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapiesComprehensive insight has been provided into the Achondroplasia epidemiology and treatment in the 7MMAdditionally, an all-inclusive account of both the current and emerging therapies for Achondroplasia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscapeA detailed review of Achondroplasia market; historical and forecasted is included in the report, covering drug outreach in the 7MMThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Achondroplasia marketList of Achondroplasia Key Players involved in the reportBioMarinAscendis PharmaTherachonPfizerAnd many othersView Report: https://www.delveinsight.com/report-store/achondroplasia-marketRequest for Sample Report: https://www.delveinsight.com/sample-request/achondroplasia-marketAchondroplasia Market ReportThe children affected by Achondroplasia are delayed in reaching gross motor milestones such as head control, and independent sitting and walking.

There are some serious neurological problems that may also occur due to narrowing of the spinal canal and nerve compression.Achondroplasia Market InsightsIt is caused by one of two mutations (G1138A and G1138C) in the FGFR3 (Fibroblast Growth Factor Receptor 3) gene at chromosome locus 4p16.3.

The mutations cause the FGFR3 protein to be overly active, which interferes with skeletal development and leads to disturbances in bone growth seen with this disorder.Achondroplasia TherapiesVosoritideTA-46TransCon CNPInfigratinib (Bridgebio/Qued)And Many othersView Report: https://www.delveinsight.com/report-store/achondroplasia-marketRequest for Sample Report: https://www.delveinsight.com/sample-request/achondroplasia-marketAchondroplasia Treatment MarketThe current market is occupied with this symptomatic treatment and surgery only.

To be effective, a new treatment approach must consider Achondroplasia is a complex disease, correcting the short stature and preventing complications.

Global Hemophilia Treatment Market Should Grow to US$21.3 Bn by 2027

Fairfield Market Research 2023-04-17

These factors are poised to generate favourable business outcomes for the global hemophilia treatment market. In the near future, leading manufacturers are projected to engage in open innovation and strategic partnerships, creating headways for robust growth in the global hemophilia treatment market. The global hemophilia treatment market recorded a revenue of US$ 14,785. In this region, the presence of key market players, higher per capita income, availability of government rebates, strong R&D in the health sector, and widespread awareness about hemophilia treatment are the major factors that contribute to the growth of the global hemophilia treatment market. com/report/hemophilia-treatment-market/request-sample About Us Fairfield Market Research is a UK-based market research provider.

Global Conjunctivitis Treatment Market Report 2024: Growth Rate, Major Segments And Regions

saikiran TBRC 2024-02-29

Learn More On The Conjunctivitis Treatment Market:https://www. The rising prevalence of conjunctivitis cases is expected to propel the growth of the conjunctivitis treatment market going forward. Therefore, the rising prevalence of conjunctivitis cases drives the demand for the conjunctivitis treatment market. Major companies operating in the conjunctivitis treatment market are concentrating on creating innovative products to strengthen their position in the market. info/ Healthcare Blog: https://healthcareresearchreports.

Acne Treatment Market Future Scope, Demand, Growth and Industry Analysis Report 2033

amols shinde 2024-01-30

Europe having the second-largest market share in Acne Treatment Market due to the rising demand for targeted medication, focus on R&D on Acne Treatment found in Europe. Asia-Pacific is estimated the fastest growing CAGR in Acne Treatment Market in forecasted period. Key Players in the Acne Treatment Market:Bausch Health Companies IncGaldermaPfizer IncAlmirallBayer AGTeva Pharmaceutical Industries LtdGlaxoSmithKline PlcJohnson & JohnsonServices, IncSkin Better ScienceRevision SkincareGlow Biotics LLC. license=singleAbout We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. Robbin Joseph Corporate Sales, USA We Market Research USA: +1-724-618-3925 Websites: https://wemarketresearch.

Fibromyalgia Treatment Market is Estimated to Witness High Growth Owing to Increasing Awareness About the Disease

Purvaja 2024-02-16

As awareness about fibromyalgia is increasing, more people are getting diagnosed and seeking medical treatment which is driving the growth of fibromyalgia treatment market. The fibromyalgia treatment market comprises of drugs for pain management and supplements. The Global Fibromyalgia Treatment Market Demand is estimated to be valued at US$ 1781. The key opportunities in the fibromyalgia treatment market include increasing adoption of alternative therapies like acupuncture, development of disease modifying drugs and new drug delivery methods. The fibromyalgia treatment market is expanding globally with growth witnessed across regions.

COPD Treatment Market Size, Share, Growth & Forecast to 2030

Ahasan Ali 2024-01-04

The COPD treatment market is expected to register a CAGR of approx. Global COPD Treatment Market SegmentationMarket Insight, by Type· Chronic bronchitis· EmphysemaMarket Insights, by Drug Class· Bronchodilators· Corticosteroids· Combination drugs· Roflumilast (phosphodiesterase-4 inhibitor)· OthersMarket Insights, by Distribution Channel· Hospital Pharmacies· Retails Pharmacies· Online PharmaciesMarket Insight, by Region· North America COPD treatment Marketo U. o Canadao Rest of North America· Europe COPD treatment Marketo Germanyo U. o Franceo Italyo Spaino Rest of Europe· Asia-Pacific COPD treatment Marketo Chinao Indiao Japano Rest of Asia-Pacific· Rest of the World COPD treatment MarketTop Company Profiles· GSK plc· Cipla Inc. A· Teva Pharmaceutical Industries Ltd.